2022 Q4 Form 20-F Financial Statement

#000117891323000949 Filed on March 13, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $72.63M $239.8M $63.42M
YoY Change 14.51% 11.57% 48.78%
Cost Of Revenue $44.91M $152.9M $38.83M
YoY Change 15.65% 6.42% 32.4%
Gross Profit $27.72M $86.91M $24.59M
YoY Change 12.71% 21.95% 84.89%
Gross Profit Margin 38.16% 36.24% 38.77%
Selling, General & Admin $11.50M $40.54M $10.23M
YoY Change 12.37% 9.29% 22.81%
% of Gross Profit 41.47% 46.65% 41.6%
Research & Development $10.10M $35.64M $8.452M
YoY Change 19.47% 11623.68%
% of Gross Profit 36.43% 41.01% 34.37%
Depreciation & Amortization $3.004M $11.61M $3.789M
YoY Change -20.72% 5.61% 49.76%
% of Gross Profit 10.84% 13.36% 15.41%
Operating Expenses $21.59M $76.96M $18.68M
YoY Change 15.58% 12.45% 21.79%
Operating Profit $6.123M $9.953M $5.908M
YoY Change 3.64% 251.45% -389.61%
Interest Expense -$102.0K $3.816M -$264.0K
YoY Change -61.36% -1773.68% 38.95%
% of Operating Profit -1.67% 38.34% -4.47%
Other Income/Expense, Net -$1.779M
YoY Change 19.08%
Pretax Income $5.968M $7.135M $4.993M
YoY Change 19.53% 1454.47% -92.02%
Income Tax $11.99M $13.06M $2.969M
% Of Pretax Income 200.87% 183.08% 59.46%
Net Earnings -$6.020M -$5.928M $2.024M
YoY Change -397.43% 95.45% -96.76%
Net Earnings / Revenue -8.29% -2.47% 3.19%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.11 -$0.10 $35.80K
COMMON SHARES
Basic Shares Outstanding 56.61M shares 56.59M shares
Diluted Shares Outstanding 56.59M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.59M $86.59M $81.86M
YoY Change 5.78% 5.78% -7.82%
Cash & Equivalents $86.59M $86.59M $81.86M
Short-Term Investments
Other Short-Term Assets $19.28M $19.82M $23.95M
YoY Change -19.47% 9.68% -45.33%
Inventory $33.02M $33.02M $28.43M
Prepaid Expenses $6.404M $5.857M
Receivables $50.64M $75.62M $65.17M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $215.1M $215.1M $199.4M
YoY Change 7.85% 7.85% -14.57%
LONG-TERM ASSETS
Property, Plant & Equipment $76.58M $80.47M $76.87M
YoY Change -0.38% 4.68% -6.37%
Goodwill $43.47M $43.47M
YoY Change 0.0%
Intangibles $309.0K $640.0K
YoY Change -51.72%
Long-Term Investments
YoY Change
Other Assets $10.74M $34.96M $24.36M
YoY Change -55.92% 43.53% -6.32%
Total Long-Term Assets $170.4M $170.4M $168.3M
YoY Change 1.2% 1.2% 4.94%
TOTAL ASSETS
Total Short-Term Assets $215.1M $215.1M $199.4M
Total Long-Term Assets $170.4M $170.4M $168.3M
Total Assets $385.4M $385.4M $367.7M
YoY Change 4.81% 4.81% -6.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.67M $20.67M $19.78M
YoY Change 4.51% 4.51% -3.53%
Accrued Expenses $50.36M $52.30M $51.02M
YoY Change -1.3% -16.47% 5.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $125.8M $125.8M $108.5M
YoY Change 15.92% 15.92% -26.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.988M $15.50M $10.90M
YoY Change -45.08% 42.14% -13.46%
Total Long-Term Liabilities $15.50M $15.50M $10.90M
YoY Change 42.14% 42.14% -13.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $125.8M $125.8M $108.5M
Total Long-Term Liabilities $15.50M $15.50M $10.90M
Total Liabilities $141.3M $141.3M $119.4M
YoY Change 18.32% 18.32% -25.37%
SHAREHOLDERS EQUITY
Retained Earnings -$683.8M -$677.9M
YoY Change 0.87%
Common Stock $934.8M $932.6M
YoY Change 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $244.1M $244.1M $248.3M
YoY Change
Total Liabilities & Shareholders Equity $385.4M $385.4M $367.7M
YoY Change 4.81% 4.81% -6.62%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$6.020M -$5.928M $2.024M
YoY Change -397.43% 95.45% -96.76%
Depreciation, Depletion And Amortization $3.004M $11.61M $3.789M
YoY Change -20.72% 5.61% 49.76%
Cash From Operating Activities $16.78M $10.81M $5.172M
YoY Change 224.52% -42.79% -91.44%
INVESTING ACTIVITIES
Capital Expenditures $3.568M $12.79M -$3.909M
YoY Change -191.28% -243.21% 97.42%
Acquisitions $0.00
YoY Change
Other Investing Activities $4.006M $4.629M -$2.159M
YoY Change -285.55% -314.4%
Cash From Investing Activities $438.0K -$8.164M -$6.068M
YoY Change -107.22% -26.4% 206.46%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities 0.000 $0.00 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities 16.78M $10.81M 5.172M
Cash From Investing Activities 438.0K -$8.164M -6.068M
Cash From Financing Activities 0.000 $0.00 0.000
Net Change In Cash 17.22M $2.682M -896.0K
YoY Change -2022.1% -108.6% -102.33%
FREE CASH FLOW
Cash From Operating Activities $16.78M $10.81M $5.172M
Capital Expenditures $3.568M $12.79M -$3.909M
Free Cash Flow $13.22M -$1.979M $9.081M
YoY Change 45.53% -107.11% -85.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
2159000 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
4587000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-53633000 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
771000 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
651000 usd
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2020 us-gaap Dividends
Dividends
19999000 usd
CY2020 us-gaap Dividends Cash
DividendsCash
35003000 usd
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7463000 usd
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4006000 usd
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2022 gilt Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
0 usd
CY2021 gilt Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
0 usd
CY2020 gilt Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
155000 usd
CY2022 gilt Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
0 usd
CY2021 gilt Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
0 usd
CY2020 gilt Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
35003000 usd
CY2022 us-gaap Revenues
Revenues
239840000 usd
CY2021 us-gaap Revenues
Revenues
214970000 usd
CY2020 us-gaap Revenues
Revenues
166135000 usd
CY2021Q4 gilt Retention Payable Credit
RetentionPayableCredit
2966000 usd
CY2021 gilt Reduction In Cost Of Revenue
ReductionInCostOfRevenue
1679000 usd
CY2021 gilt Reduction In Operation Expenses
ReductionInOperationExpenses
1287000 usd
CY2021Q4 gilt Amount Receivable From Cares Act
AmountReceivableFromCaresAct
952000 usd
CY2022Q4 gilt Amount Receivable From Cares Act
AmountReceivableFromCaresAct
952000 usd
CY2020 us-gaap Advertising Expense
AdvertisingExpense
128000 usd
CY2021 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
58000 usd
CY2022 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
16169000 usd
CY2021 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
22958000 usd
CY2020 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
19470000 usd
CY2022 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3078000 usd
CY2021 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3028000 usd
CY2020 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1705000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
309000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
233000 usd
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
233000 usd
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
470000 usd
CY2020 us-gaap Product Warranty Expense
ProductWarrantyExpense
49000 usd
CY2022 gilt Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
641000 usd
CY2021 gilt Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
1695000 usd
CY2020 gilt Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
1386000 usd
CY2022 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-490000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-771000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-651000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
105647000 usd
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
105647000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
62179000 usd
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
62179000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
43468000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
43468000 usd
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
24864000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M3D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.048 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1934000 usd
CY2021Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
24000 usd
CY2022Q4 gilt Estimated Net Amount
EstimatedNetAmount
635000 usd
CY2019Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.45
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
19999000 usd
CY2020Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.36
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
35003000 usd
CY2021Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.63
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.08
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.72
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
565000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14318000 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
424000 usd
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
19999000 usd
CY2021Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.36
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
35003000 usd
CY2021Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.63
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18265000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17551000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.06 pure
CY2022Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
115472000 usd
CY2021Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
130663000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13063000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3492000 usd
CY2022 gilt Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
0 usd
CY2021 gilt Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
0 usd
CY2020 gilt Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
7749000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14940000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1140000 usd
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
808000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1877000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2352000 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
793000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
12154000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2719000 usd
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
325000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
909000 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
773000 usd
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
468000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13063000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3492000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
793000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7523000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5537000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
44387000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
14658000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5996000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8518000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7135000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
459000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35869000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
129000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
195000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2908000 usd
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
3604000 usd
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
3727000 usd
CY2022Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
21000 usd
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
617000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5988000 usd
CY2022 gilt Bank Charges
BankCharges
1752000 usd
CY2021 gilt Bank Charges
BankCharges
1986000 usd
CY2020 gilt Bank Charges
BankCharges
2201000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5928000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3033000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
35076000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
152932000 usd
CY2022 us-gaap Gross Profit
GrossProfit
86908000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35640000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21694000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18850000 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
771000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
143703000 usd
CY2021 us-gaap Gross Profit
GrossProfit
71267000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31336000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21512000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15587000 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
651000 usd
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
124755000 usd
CY2020 us-gaap Gross Profit
GrossProfit
41380000 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26303000 usd
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16871000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14063000 usd
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-53633000 usd
CY2015 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1750000 usd

Files In Submission

Name View Source Status
gilt-20221231_pre.xml Edgar Link unprocessable
0001178913-23-000949-index-headers.html Edgar Link pending
0001178913-23-000949-index.html Edgar Link pending
0001178913-23-000949.txt Edgar Link pending
0001178913-23-000949-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gilt-20221231.xsd Edgar Link pending
gilt_img01.jpg Edgar Link pending
image00002.jpg Edgar Link pending
image00003.jpg Edgar Link pending
image00004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gilt-20221231_cal.xml Edgar Link unprocessable
gilt-20221231_def.xml Edgar Link unprocessable
gilt-20221231_lab.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2329347.htm Edgar Link pending
zk2329347_htm.xml Edgar Link completed